Eric R First from 13 Normandy Blvd W, Morristown, NJ 07960, age 61, Phone: 6172687828

Name / Title

Company / Classification

Phones & Addresses

Eric First
Manager

5THSB, LLC

52 N St S, Boston, MA 02127

Eric R. First
Treasurer

RESEARCH SOFTWARE ASSOCIATES, INC

52 N St, Boston, MA 02127

Eric First
Treasurer

FIRST THOUGHTS, INC

52 N St, Boston, MA 02127

Methods For Treating A Buttock Deformity
view source
US Patent:

7179474, Feb 20, 2007
Filed:

Sep 3, 2004
Appl. No.:

10/934810
Inventors:

Eric R. First - Boston MA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/08
A61K 39/02
US Classification:

4242391, 424 91, 4242361, 514 2, 514 12, 530350, 530412
Abstract:

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.

Method For Treating Peritoneal Adhesions
view source
US Patent:

7419675, Sep 2, 2008
Filed:

May 26, 2005
Appl. No.:

11/139318
Inventors:

Eric R. First - Boston MA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/02
A61K 39/00
A61K 39/08
A61K 38/00
US Classification:

4242361, 4241841, 4242341, 4242471, 530300
Abstract:

Methods for treating peritoneal adhesions by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a peritoneal adhesion.

Stretch Mark Treatment
view source
US Patent:

7429386, Sep 30, 2008
Filed:

Sep 3, 2004
Appl. No.:

10/934812
Inventors:

Eric R. First - Boston MA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/02
A61K 39/00
A61K 39/08
A61K 38/00
US Classification:

4242361, 4241841, 4242341, 4242471, 530300, 530324
Abstract:

Methods for treating stretch marks by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a stretch mark.

Buttock Deformity Treatment
view source
US Patent:

7438921, Oct 21, 2008
Filed:

Jan 11, 2007
Appl. No.:

11/622420
Inventors:

Eric R. First - Boston MA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/08
A61K 39/02
US Classification:

4242391, 424 91, 4242361, 514 2, 514 12, 530350, 530412
Abstract:

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.

Methods For Treating Eye Disorders
view source
US Patent:

7465458, Dec 16, 2008
Filed:

Apr 19, 2007
Appl. No.:

11/737641
Inventors:

Eric R. First - Boston MA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/08
A61F 2/00
A01N 43/56
US Classification:

4242471, 424423, 514406, 604511, 604531
Abstract:

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivitis, fungal conjunctivitis, viral conjunctivitis, uveitis, keratic precipitates, macular edema, and inflammation response after intra-ocular lens implantation. The toxin may be produced by a , a , a bacterium and/or a.

Methods For Enhancing Therapeutic Effects Of A Neurotoxin
view source
US Patent:

7824694, Nov 2, 2010
Filed:

Jan 12, 2006
Appl. No.:

11/330893
Inventors:

Eric R. First - Boston MA, US
Ryan A. Irvine - Los Angeles CA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/08
A61K 35/30
A61K 38/00
US Classification:

4242471, 4242391, 424570, 514 2
Abstract:

The present invention relates to methods for enhancing the therapeutic effects of a neurotoxin, e. g. , a toxin, where the methods comprise a “wash-down” (e. g. , a decreased intake) of a current pain medication and an administration of a neurotoxin. In some embodiments, the present inventions relates to methods for enhancing the therapeutic effects of a neurotoxin for treating pain, e. g. , headache pain.